CIK 0001714899 · Large accelerated filer
Denali Therapeutics Inc.
Sign in to watch- Ticker
- DNLI
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 463872213
- Phone
- (650) 866-8547
- Business address
- 161 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $363,678
- in 3 filings, $327K under 10b5-1 plans
Net −$363,678. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 8 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-06-02 | Cook Jennifer E. Director | Grant or award · Stock Option (right to buy) | +17,959 | 17,959 | ||
| 2022-06-02 | FLATLEY JAY T Director | Grant or award | +5,986 | 336,313 | ||
| 2022-06-02 | FLATLEY JAY T Director | Grant or award · Stock Option (right to buy) | +17,959 | 17,959 | ||
| 2022-06-02 | Thornberry Nancy Director | Grant or award | +5,986 | 8,497 | ||
| 2022-06-02 | Thornberry Nancy Director | Grant or award · Stock Option (right to buy) | +17,959 | 17,959 | ||
| 2022-03-23 | Tessier-Lavigne Marc Director | Sale | −8,402 | $33.40 | $281K | 2,035,968 |
| 2022-03-23 | Tessier-Lavigne Marc Director | Sale | −11,598 | $34.14 | $396K | 2,024,370 |
| 2022-03-23 | Tessier-Lavigne Marc Director | Sale | −8,402 | $33.40 | $281K | 2,035,968 |
| 2022-03-23 | Tessier-Lavigne Marc Director | Sale | −11,598 | $34.14 | $396K | 2,024,370 |
| 2022-02-11 | Watts Ryan J. President and CEO | Sale | −9,491 | $34.72 | $330K | 2,129,648 |
| 2022-02-11 | Krognes Steve E. CFO and Treasurer | Sale | −2,560 | $34.69 | $89K | 120,221 |
| 2022-02-11 | Schuth Alexander O. COO and Secretary | Sale | −2,803 | $34.68 | $97K | 465,047 |
| 2022-02-11 | Ho Carole Chief Medical Officer | Sale | −2,918 | $34.71 | $101K | 170,663 |
| 2022-02-10 | Watts Ryan J. President and CEO | Option exercise | +64,631 | $5.28 | $341K | 254,522 |
| 2022-02-10 | Watts Ryan J. President and CEO | Option exercise | +6,118 | $9.60 | $59K | 260,640 |
| 2022-02-10 | Watts Ryan J. President and CEO | Option exercise · Stock Option (right to buy) | −64,631 | 0 | ||
| 2022-02-10 | Watts Ryan J. President and CEO | Option exercise · Stock Option (right to buy) | −6,118 | 0 | ||
| 2022-02-09 | Krognes Steve E. CFO and Treasurer | Sale | −1,296 | $37.09 | $48K | 122,781 |
| 2022-02-09 | Watts Ryan J. President and CEO | Sale | −2,719 | $37.55 | $102K | 2,119,442 |
| 2022-02-09 | Schuth Alexander O. COO and Secretary | Sale | −1,423 | $37.10 | $53K | 460,564 |
Page 16 of 53 · 1,043 trades